Exact Mass: 340.1085964
Exact Mass Matches: 340.1085964
Found 183 metabolites which its exact mass value is equals to given mass value 340.1085964,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Diphacinone
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
3'-Ketolactose
3-Ketolactose is a metabolite in galactose metabolism (KEGG). [HMDB]. 3-Ketolactose is found in many foods, some of which are lentils, fireweed, cardamom, and elliotts blueberry. 3-Ketolactose is a metabolite in galactose metabolism (KEGG).
3,4,5-trihydroxy-6-[(2,3,5-trihydroxy-6-methyloxan-4-yl)oxy]oxane-2-carboxylic acid
Oenanthoside A
Oenanthoside A is found in herbs and spices. Oenanthoside A is a constituent of Oenanthe javanica (water dropwort) Constituent of Oenanthe javanica (water dropwort). Oenanthoside A is found in herbs and spices.
4-O-beta-D-Glucopyranuronosyl-L-fucose
4-O-beta-D-Glucopyranuronosyl-L-fucose is isolated from the partial acid hydrolysate of tragacanthic acid, the major polysaccharide component of tragacanth gum. Isolated from the partial acid hydrolysate of tragacanthic acid, the major polysaccharide component of tragacanth gum
Linocinnamarin
Linocinnamarin is found in coffee and coffee products. Linocinnamarin is a glycoside from seeds of Linum usitatissimum (flax
2-O-a-D-Galactopyranuronosyl-L-rhamnose
2-O-a-D-Galactopyranuronosyl-L-rhamnose is found in coffee and coffee products. 2-O-a-D-Galactopyranuronosyl-L-rhamnose is isolated from partial acid hydrolysates of Linum usitatissimum (flax), Plantago seed, Hibiscus esculentus (okra). Isolated from partial acid hydrolysates of Linum usitatissimum (flax), Plantago seed, Hibiscus esculentus (okra). 2-O-a-D-Galactopyranuronosyl-L-rhamnose is found in coffee and coffee products, fats and oils, and fruits.
2-O-(4-O-Methyl-a-D-glucopyranuronosyl)-D-xylose
2-O-(4-O-Methyl-a-D-glucopyranuronosyl)-D-xylose is found in cereals and cereal products. 2-O-(4-O-Methyl-a-D-glucopyranuronosyl)-D-xylose is an important aldobiouronic acid that occurs as a structural unit of polysaccharides. 2-O-(4-O-Methyl-a-D-glucopyranuronosyl)-D-xylose is widely distributed in plant
4-O-(4-O-Methyl-alpha-D-glucopyranuronosyl)-L-arabinose
4-O-(4-O-Methyl-alpha-D-glucopyranuronosyl)-L-arabinose is found in citrus. 4-O-(4-O-Methyl-alpha-D-glucopyranuronosyl)-L-arabinose is isolated from the partial hydrolysates of lemon gum. Isolated from the partial hydrolysates of lemon gum. 4-O-(4-O-Methyl-alpha-D-glucopyranuronosyl)-L-arabinose is found in citrus and fruits.
3-O-(4-O-Methyl-a-D-glucopyranuronosyl)-L-arabinose
3-O-(4-O-Methyl-a-D-glucopyranuronosyl)-L-arabinose is found in fruits. 3-O-(4-O-Methyl-a-D-glucopyranuronosyl)-L-arabinose is isolated from the autohydrolysate of golden apple (Spondias cytherea) gum. Isolated from the autohydrolysate of golden apple (Spondias cytherea) gum. 3-O-(4-O-Methyl-a-D-glucopyranuronosyl)-L-arabinose is found in fruits.
trans-isoeugenol-O-glucuronide
trans-isoeugenol-O-glucuronide is a conjugate of trans-isoeugenol and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. Glucuronidation, the conversion of chemical compounds to glucuronides, is a method that animals use to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Enzymes that cleave the glycosidic bond of a glucuronide are called glucuronidases. (Wikipedia)
N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide
C16H21ClN2O2S (340.10121960000004)
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D004791 - Enzyme Inhibitors
Methyl 6-O-p-trans-coumaroyl-beta-D-glucopyranoside
CP-863187
C18H14F2N4O (340.11356179999996)
CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8284; ORIGINAL_PRECURSOR_SCAN_NO 8283 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8325; ORIGINAL_PRECURSOR_SCAN_NO 8323 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8328; ORIGINAL_PRECURSOR_SCAN_NO 8326 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8370; ORIGINAL_PRECURSOR_SCAN_NO 8368 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8368; ORIGINAL_PRECURSOR_SCAN_NO 8366 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8380; ORIGINAL_PRECURSOR_SCAN_NO 8379
4-(3-glucopyranosyloxy-4-hydroxyphenyl)-3-buten-2-one|4-(3-glucopyranosyloxy-4-hydroxyphenyl)-(E)-3-buten-2-one
2-O-(4-O-methyl-alpha-D-glucopyranosyluronic acid)-D-xylose|O4-methyl-O1-D-xylose-2-yl-alpha-D-glucopyranuronic acid|O4-Methyl-O1-D-xylose-2-yl-alpha-D-glucopyranuronsaeure
4alpha-hydroxy-3beta-chloro-8alpha-acetoxyguai-1(10),11(13)-dien-6alpha,12-olide
C17H21ClO5 (340.10774460000005)
2-O-(4-O-Methyl-alpha-D-glucopyranuronosyl)-D-xylose|4-Me-2-O-alpha-D-Glucopyranuronosyl-D-xylose,,
methyl 16-bromo-(7E,15E)-hexadeca-7,15-diene-5-triynoate
C17H25BrO2 (340.10378099999997)
2-methoxy-4-(2-carboxyvinyl)phenyl alpha-L-rhamnopyranoside
(SC2RC7)-gamma-glutamyl-S-benzylcysteine|(SC2RC7)-??-Glutamyl-S-benzylcysteine
C15H20N2O5S (340.10928700000005)
2-beta-D-glucopyranosyloxy-trans-cinnamic acid methyl ester|2-beta-D-Glucopyranosyloxy-trans-zimtsaeure-methylester|Methyl o-coumarate-beta-D-glucoside
O-4-O-Methyl-alpha-D-glucuronopyranosyl-(1->3)-D-xylopyranose
(2S*,2R*,3aR*,7aS*)-2,7a-dihydroxy-6,7,3a,7a-tetrahydrospiro[1,3-benzodioxole-2,1-cyclohex-3-ene]-2,3a-dicarboxylate|(?)-idesolide|idesolide
alpha-(o-Nitro-p-tolylazo)acetoacetanilide
http://casmi-contest.org/challenges-cat1-2.shtml; CASMI2012 LC Challenge 12
N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide
C16H21ClN2O2S (340.10121960000004)
LINOCINNAMARIN
Oenanthoside A
ETHYL 3-(SEC-BUTYLTHIO)-6,6-DIMETHYL-4-OXO-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBOXYLATE
3-methoxy-4-[(1-methyl-5-nitroindol-3-yl)methyl]benzoic acid
BENZYL (2-((1,3-DIOXOISOINDOLIN-2-YL)OXY)ETHYL)CARBAMATE
3-(3-CARBAMOYL-BENZENESULFONYL)-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C15H20N2O5S (340.10928700000005)
3-(4-CARBAMOYL-BENZENESULFONYL)-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C15H20N2O5S (340.10928700000005)
2-(2,4-BIS(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
3-hydroxy-N-[(Z)-(3-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]naphthalene-2-carbohydrazide,hydrate
2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
(3aR,4R,5R,6aS)-4-((E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2,5-diol
C17H21ClO5 (340.10774460000005)
(2S)-1-[4-(2-acetamidoethyl)phenyl]sulfonylproline
C15H20N2O5S (340.10928700000005)
5-(2-chlorophenyl)-6-[4-(dimethylamino)phenyl]-2-methyl-1,2,4-triazin-3-one
3-(3-(4-(2-methoxyethoxy)phenyl)-1,2,4-oxadiazol-5-yl)benzoicacid
Enarodustat
C78275 - Agent Affecting Blood or Body Fluid Enarodustat is a potent and orally active hypoxia-inducible factor prolyl hydroxylase inhibitor, with an EC50 of 0.22 μM. Enarodustat has the potential for renal anemia treatment.
3-Ketolactose
A keto-disaccharide that is beta-D-galactosyl-(1->4)-beta-D-glucose in which the hydroxy group at position 3 of the galactosyl moiety has been oxidised to the corresponding ketone.
N-[amino-[2-(1H-indol-3-yl)ethylimino]methyl]-4-chlorobenzamide
N-(6-aminohexyl)-5-chloronaphthalene-2-sulfonamide
C16H21ClN2O2S (340.10121960000004)
N-(5-methyl-3-isoxazolyl)-2-[[6-(4-methylphenyl)-3-pyridazinyl]thio]acetamide
1,2,4-Triazolo(4,3-a)pyridine, 6-(4-(2,5-difluorophenyl)-5-oxazolyl)-3-(1-methylethyl)-
C18H14F2N4O (340.11356179999996)
1-(N-Imidazolyl)-2-hydroxy-2-(2,3-dichlorophenyl)octane
3,4,5-Trihydroxy-6-(2,3,5-trihydroxy-6-methyloxan-4-yl)oxyoxane-2-carboxylic acid
Protodeoxyviolaceinate
A monocarboxylic acid anion that is the conjugate base of protodeoxyviolaceinic acid, resulting from the removal of the proton from the carboxy group. Major structure at pH 7.3.
Galactopyranose, 6-deoxy-4-O-beta-D-glucopyranuronosyl-, L-
7-Amino-5-(4-ethoxy-3-methoxyphenyl)-4-oxo-3,5-dihydropyrano[2,3-d]pyrimidine-6-carbonitrile
4-[[(1-Methylsulfonyl-4-piperidinyl)-oxomethyl]amino]benzoic acid methyl ester
C15H20N2O5S (340.10928700000005)
3,4-dimethyl-N-[[(2-oxo-1,3-dihydrobenzimidazol-5-yl)amino]-sulfanylidenemethyl]benzamide
1-(4-Fluorophenyl)-2-[(2-propyl-4-quinazolinyl)thio]ethanone
C19H17FN2OS (340.10455640000004)
N-[(E)-(1-acetylindol-3-yl)methylideneamino]-2,4-dimethyl-1,3-thiazole-5-carboxamide
(2S,3R,4R,5R,6S)-4,5,6-trihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxane-2-carboxylic acid
(2R,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-one
6-(2-Benzyl-3-oxopropoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
2-methoxy-4-[(Z)-(7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-12-ylhydrazinylidene)methyl]phenol
3,4,5-Trihydroxy-6-[(2-methyl-3-phenyloxiran-2-yl)methoxy]oxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[1-(3-phenyloxiran-2-yl)ethoxy]oxane-2-carboxylic acid
Diphacinone
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
methyl (E)-3-[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoate
3-O-(4-O-Methyl-a-D-glucopyranuronosyl)-L-arabinose
4-O-(4-O-Methyl-alpha-D-glucopyranuronosyl)-L-arabinose
coniferaldehyde beta-D-glucoside
A beta-D-glucoside that is coniferaldehyde in which the phenolic hydrogen has been replaced by a beta-D-glucosyl residue.
2',7a-dimethyl 2',3a-dihydroxy-4,5-dihydrospiro[1,3-benzodioxole-2,1'-cyclohexan]-3'-ene-2',7a-dicarboxylate
2-ethoxy-5-hydroxy-6-methyl-4-oxooxan-3-yl 2,4-dihydroxy-6-methylbenzoate
methyl 3-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate
6-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one
methyl (2e)-3-{3-hydroxy-5-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl}prop-2-enoate
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2s,3r,4r,5s,6s)-2,3,5-trihydroxy-6-methyloxan-4-yl]oxy}oxane-2-carboxylic acid
methyl (2e)-4-{4,8-dimethoxy-9h-pyrido[3,4-b]indol-1-yl}-4-oxobut-2-enoate
3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enal
methyl (2e)-3-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate
(2s,3s,5r,6s)-2-ethoxy-5-hydroxy-6-methyl-4-oxooxan-3-yl 2,4-dihydroxy-6-methylbenzoate
1,2,3,4,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one
(4s,7e,9r,10s,13e,16s)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12,15-tetrone
(2s,3s,6r)-2-bromo-1,1,9-trimethyl-5-methylidenespiro[5.5]undec-8-en-3-yl acetate
C17H25BrO2 (340.10378099999997)
2',7a-dimethyl (2r,2's,3ar,7as)-2',3a-dihydroxy-4,5-dihydrospiro[1,3-benzodioxole-2,1'-cyclohexan]-3'-ene-2',7a-dicarboxylate
(1r,2s,3r,4s,4ar,9as,10s)-1,2,3,4,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one
(2s,3r,4r,5r,6s)-2,4,5-trihydroxy-6-methyloxan-3-yl (2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate
(4s)-6-hydroxy-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one
(2s,3s,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-{[(2r,3r,4s,5r)-2,4,5-trihydroxyoxan-3-yl]oxy}oxane-2-carboxylic acid
(2s,3s,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-{[(2r,3s,4r)-3,4,5-trihydroxy-1-oxopentan-2-yl]oxy}oxane-2-carboxylic acid
(3ar,4s,8s,9s,9as,9bs)-8-chloro-9-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
C17H21ClO5 (340.10774460000005)
2-amino-4-{[2-(benzylsulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid
C15H20N2O5S (340.10928700000005)
3-(chloromethyl)-3-hydroxy-6,9-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-8-yl acetate
C17H21ClO5 (340.10774460000005)
methyl (2e)-3-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate
4-(4-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)but-3-en-2-one
(3s,3ar,6ar,8s,9ar,9br)-3-(chloromethyl)-3-hydroxy-6,9-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-8-yl acetate
C17H21ClO5 (340.10774460000005)
6-(2,4-dihydroxy-5-methoxy-3-methylphenoxy)-4,5-dihydroxy-3-methoxy-5-methylcyclohex-2-en-1-one
(1r,2r,3s,4as,9ar,10r)-1,2,3,4a,8,10-hexahydroxy-6-methoxy-3-methyl-2,4,9a,10-tetrahydro-1h-anthracen-9-one
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
methyl 4-{4,8-dimethoxy-9h-pyrido[3,4-b]indol-1-yl}-4-oxobut-2-enoate
(1s,2r,3s,4as,9ar,10r)-1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one
(2e)-3-(4-{[(2s,3s,4s,5r)-3,4-dihydroxy-5-[(1s)-1-hydroxyethyl]oxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enoic acid
(2s,3r,4r,5s,6s)-2,3,5-trihydroxy-6-methyloxan-4-yl (2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate
[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (2e)-3-(4-methoxyphenyl)prop-2-enoate
(4r,5s,6r)-6-(2,4-dihydroxy-5-methoxy-3-methylphenoxy)-4,5-dihydroxy-3-methoxy-5-methylcyclohex-2-en-1-one
methyl 3-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate
(2s)-2-amino-4-{[(1r)-2-(benzylsulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid
C15H20N2O5S (340.10928700000005)
(3as,6s,6ar,8s,9ar,9bs)-6-(chloromethyl)-6-hydroxy-3,9-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-8-yl acetate
C17H21ClO5 (340.10774460000005)
(1r,2s,3r,4ar,9as,10s)-1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one
1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one
2,4,5-trihydroxy-6-methyloxan-3-yl 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[6-(prop-2-en-1-yl)-2h-1,3-benzodioxol-4-yl]oxy}oxane-3,4,5-triol
4,5-dihydroxy-3-methoxy-6-[(3,4,5-trihydroxy-1-oxopentan-2-yl)oxy]oxane-2-carboxylic acid
(7e,13e)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12,15-tetrone
3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-1-oxohexan-2-yl)oxy]oxane-2-carboxylic acid
(4s)-5-hydroxy-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one
(3,4,5-trihydroxy-6-methoxyoxan-2-yl)methyl 3-(4-hydroxyphenyl)prop-2-enoate
2-bromo-1,1,9-trimethyl-5-methylidenespiro[5.5]undec-8-en-3-yl acetate
C17H25BrO2 (340.10378099999997)
(2e)-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enal
8-chloro-9-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
C17H21ClO5 (340.10774460000005)
(2r,3s,6r)-2-bromo-1,1,9-trimethyl-5-methylidenespiro[5.5]undec-8-en-3-yl acetate
C17H25BrO2 (340.10378099999997)
(3e)-4-(4-hydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)but-3-en-2-one
3,4,5-trihydroxy-6-[(4,5,6-trihydroxy-2-methyloxan-3-yl)oxy]oxane-2-carboxylic acid
(2s,3r,4r,5r,6s)-4,5,6-trihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxane-2-carboxylic acid
{4-[(1s,4s)-4-bromo-3,3-dimethylcyclohexyl]cyclohexa-1,3-dien-1-yl}methyl acetate
C17H25BrO2 (340.10378099999997)
(1s,2r,3s,4as,9ar,10s)-1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one
(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2r,3s,4r,5r)-3,4,5-trihydroxy-1-oxohexan-2-yl]oxy}oxane-2-carboxylic acid
[4-(4-bromo-3,3-dimethylcyclohexyl)cyclohexa-1,3-dien-1-yl]methyl acetate
C17H25BrO2 (340.10378099999997)